Target intelligence / Profile preview

Free fatty acid metabolism

Molecular classification
Other (metabolic pathway/process), Enzyme (involved enzymes such as fatty acid synthase, acyl-CoA synthetase, carnitine palmitoyltransferases), Transporter (e.g., SLC27 family fatty acid transport proteins), Receptor (free fatty acid receptors/FFARs are involved in signaling)
01

Overview

Free fatty acid metabolism" refers to the complex network of biochemical processes involving the synthesis, breakdown (β‐oxidation), transport, storage, and utilization of non‐esterified carboxylic acids known as free fatty acids. These processes are central to energy homeostasis—fatty acids serve as major energy sources during fasting or exercise when triglycerides stored in adipose tissue are hydrolyzed into FFAs that circulate bound to albumin. FFAs also play structural roles in cell membranes and act as signaling molecules by activating specific G protein-coupled receptors called free fatty acid receptors (FFARs), which regulate metabolic pathways including insulin secretion and inflammation. Dysregulation of FFA metabolism is implicated in obesity, type 2 diabetes mellitus, cardiovascular disease, and other metabolic disorders. While individual components within this system—such as certain enzymes or FFAR subtypes—are considered therapeutic targets with approved drugs under development or clinical use for conditions like type 2 diabetes,[6] "free fatty acid metabolism" itself is a broad physiological process rather than a discrete molecular entity suitable for direct pharmacological targeting.[1][3][4]

Other names
Fatty acid metabolismFFA metabolismLipid metabolism
02

Mechanism of action

Drugs targeting this system may act by: - Agonizing or antagonizing free fatty acid receptors to modulate insulin secretion or inflammation - Inhibiting key enzymes in synthesis or oxidation pathways to alter lipid levels/metabolism

03

Biological functions

Energy production/homeostasisSignal transductionCell membrane structure and integrityRegulation of gene expression via nuclear receptorsLipid storage and mobilization
04

Disease associations

Metabolic syndromeType 2 diabetesObesityCardiovascular diseaseInflammation
05

Safety considerations

Therapeutic modulation of free fatty acids can affect energy balancecause hypoglycemia/hyperglycemiaimpact cardiovascular functionpotentially disrupt cell membrane integrity if not carefully controlled
06

Interacting drugs

FFAR1/GPR40 agonists

2 more in the full profile.

07

Biomarkers

Plasma free fatty acids

Beyond the preview

Go deeper on Free fatty acid metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Free fatty acid metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call